Calcineurin inhibitors affect B cell antibody responses indirectly by interfering with T cell help.

PubWeight™: 1.04‹?› | Rank: Top 15%

🔗 View Article (PMC 2810388)

Published in Clin Exp Immunol on November 18, 2009

Authors

S Heidt1, D L Roelen, C Eijsink, M Eikmans, C van Kooten, F H J Claas, A Mulder

Author Affiliations

1: Department of Immunohaematology and Blood Transfusion, Leiden University Medical Center, Leiden, the Netherlands.

Articles citing this

The significance of donor-specific HLA antibodies in rejection and ductopenia development in ABO compatible liver transplantation. Am J Transplant (2011) 1.98

Surrogate end points in the design of immunotherapy trials: emerging lessons from type 1 diabetes. Nat Rev Immunol (2010) 1.22

B cell repopulation after alemtuzumab induction-transient increase in transitional B cells and long-term dominance of naïve B cells. Am J Transplant (2012) 1.03

Is it time to give up with calcineurin inhibitors in kidney transplantation? World J Transplant (2013) 0.86

Combination of cyclosporine A with corticosteroids is effective for the treatment of neuromyelitis optica. J Neurol (2012) 0.83

Calcineurin inhibitors dampen humoral immunity by acting directly on naive B cells. Clin Exp Immunol (2015) 0.83

Efficacy and cytokine modulating effects of tacrolimus in systemic lupus erythematosus: a review. J Biomed Biotechnol (2010) 0.83

Mycophenolic acid counteracts B cell proliferation and plasmablast formation in patients with systemic lupus erythematosus. Arthritis Res Ther (2012) 0.82

The Influence of Immunosuppressive Agents on the Risk of De Novo Donor-Specific HLA Antibody Production in Solid Organ Transplant Recipients. Transplantation (2016) 0.79

Towards new avenues in the management of lupus glomerulonephritis. Nat Rev Rheumatol (2016) 0.79

Renal transplantation dramatically reduces IgA anti-beta-2-glycoprotein I antibodies in patients with endstage renal disease. J Immunol Res (2014) 0.79

Differential Effects of Tacrolimus versus Sirolimus on the Proliferation, Activation and Differentiation of Human B Cells. PLoS One (2015) 0.79

Monitoring Pharmacologically Induced Immunosuppression by Immune Repertoire Sequencing to Detect Acute Allograft Rejection in Heart Transplant Patients: A Proof-of-Concept Diagnostic Accuracy Study. PLoS Med (2015) 0.79

Antibody Subclass Repertoire and Graft Outcome Following Solid Organ Transplantation. Front Immunol (2016) 0.78

Clinical significance of donor-specific human leukocyte antigen antibodies in liver transplantation. World J Gastroenterol (2015) 0.76

Immunosuppressive compounds exhibit particular effects on functional properties of human anti-Aspergillus Th1 cells. Infect Immun (2014) 0.76

Refractory Autoimmune Hepatitis: Beyond Standard Therapy. Dig Dis Sci (2016) 0.76

mTOR Inhibition Suppresses Posttransplant Alloantibody Production Through Direct Inhibition of Alloprimed B Cells and Sparing of CD8+ Antibody-Suppressing T cells. Transplantation (2016) 0.76

Broadening the translational immunology landscape. Clin Exp Immunol (2012) 0.75

B Cell Immunity in Solid Organ Transplantation. Front Immunol (2017) 0.75

Calcineurin inhibitors differentially alter the circadian rhythm of T-cell functionality in transplant recipients. J Transl Med (2015) 0.75

Effect of Immunosuppressive Drugs on Humoral Allosensitization after Kidney Transplant. J Am Soc Nephrol (2016) 0.75

Application of Operational Tolerance Signatures Are Limited by Variability and Type of Immunosuppression in Renal Transplant Recipients: A Cross-Sectional Study. Transplant Direct (2016) 0.75

In human cell cultures, everolimus is inferior to tacrolimus in inhibiting cellular alloimmunity, but equally effective as regards humoral alloimmunity. Int Urol Nephrol (2017) 0.75

Articles cited by this

Significance of the positive crossmatch test in kidney transplantation. N Engl J Med (1969) 5.50

The CD40 ligand, gp39, is defective in activated T cells from patients with X-linked hyper-IgM syndrome. Cell (1993) 4.30

B cell intrinsic TLR signals amplify but are not required for humoral immunity. J Exp Med (2007) 1.89

FK506 trough levels in whole blood and plasma in liver transplant recipients. Correlation with clinical events and side effects. Transplantation (1994) 1.80

Chronic humoral rejection: identification of antibody-mediated chronic renal allograft rejection by C4d deposits in peritubular capillaries. J Am Soc Nephrol (2001) 1.72

Role of lipoproteins and erythrocytes in the in vitro binding and distribution of cyclosporin A in the blood. J Pharm Pharmacol (1982) 1.65

Human ICOS deficiency abrogates the germinal center reaction and provides a monogenic model for common variable immunodeficiency. Blood (2005) 1.63

All chronic rejection failures of kidney transplants were preceded by the development of HLA antibodies. Transplantation (2002) 1.58

Inhibition of T and B lymphocyte proliferation by rapamycin. Immunology (1991) 1.48

Plasma vs whole blood for therapeutic drug monitoring of patients receiving FK 506 for immunosuppression. Clin Chem (1994) 1.43

Rituximab as treatment for refractory kidney transplant rejection. Am J Transplant (2004) 1.42

Rituximab therapy for acute humoral rejection after kidney transplantation. Transplantation (2007) 1.41

T cell-dependent activation of B cell proliferation and differentiation by immobilized monoclonal antibodies to CD3. J Immunol (1988) 1.41

B cell-mediated antigen presentation is required for the pathogenesis of acute cardiac allograft rejection. J Immunol (2006) 1.34

Two levels of help for B cell alloantibody production. J Exp Med (1996) 1.31

The mechanism of action of FK-506 and cyclosporin A. Ann N Y Acad Sci (1993) 1.30

Chronic renal allograft rejection: pathophysiologic considerations. Kidney Int (2005) 1.26

Inhibition of T-lymphocyte activation by the immunosuppressive drug FK-506. Immunology (1989) 1.22

Induction of apoptosis and modulation of activation and effector function in T cells by immunosuppressive drugs. Clin Exp Immunol (2002) 1.21

Effects of immunosuppressive drugs on purified human B cells: evidence supporting the use of MMF and rapamycin. Transplantation (2008) 1.17

Role of CD40 antigen and interleukin-2 in T cell-dependent human B lymphocyte growth. Eur J Immunol (1994) 1.15

Evidence for a critical role for IL-2 in CD40-mediated activation of naive B cells by primary CD4 T cells. J Immunol (1998) 1.07

Beneficial effect of plasmapheresis and intravenous immunoglobulin on renal allograft survival of patients with acute humoral rejection. Transplantation (2003) 1.02

Effect of cyclosporin A on T-dependent and T-independent immunoglobulin synthesis in vitro. Nature (1980) 0.99

Effects of cyclosporin A on the metabolism of unstimulated and mitogen-activated lymphocytes. Immunology (1983) 0.99

Pharmacologic aspects of cyclosporine therapy: pharmacokinetics. Transplant Proc (1985) 0.96

Treatment of C4d-positive acute humoral rejection with plasmapheresis and rabbit polyclonal antithymocyte globulin. Transplantation (2004) 0.96

Mycophenolic acid inhibits IL-2-dependent T cell proliferation, but not IL-2-dependent survival and sensitization to apoptosis. J Immunol (2002) 0.90

Human Flt-3-ligand-mobilized dendritic cells require additional activation to drive effective immune responses. Exp Hematol (2007) 0.88

Distribution and protein binding of FK506, a potent immunosuppressive macrolide lactone, in human blood and its uptake by erythrocytes. J Pharm Pharmacol (1994) 0.87

Use of ATG in treatment of steroid-resistant rejection. Transplantation (1980) 0.86

Therapy with plasmapheresis and intravenous immunoglobulin for acute humoral rejection in kidney transplantation. Transplant Proc (2005) 0.86

The effects of immunosuppressive agents on in vitro production of human immunoglobulins. Transplantation (1991) 0.77

Articles by these authors

The CD40 antigen and its ligand. Annu Rev Immunol (1994) 7.26

Anaerobic oxidation of ammonium is a biologically mediated process. Appl Environ Microbiol (1995) 3.45

Rapid detection of human cytomegalovirus DNA in peripheral blood leukocytes of viremic transplant recipients by the polymerase chain reaction. Transplantation (1989) 2.67

Should HLA mismatch acceptability for sensitized transplant candidates be determined at the high-resolution rather than the antigen level? Am J Transplant (2015) 2.24

Fas ligation induces apoptosis of CD40-activated human B lymphocytes. J Exp Med (1995) 2.19

Clinical findings with implications for genetic testing in families with clustering of colorectal cancer. N Engl J Med (1998) 2.17

Interleukin-6 induced at mucosal surfaces by gram-negative bacterial infection. Infect Immun (1989) 2.13

Hereditary nonpolyposis colorectal cancer families not complying with the Amsterdam criteria show extremely low frequency of mismatch-repair-gene mutations. Am J Hum Genet (1997) 1.63

Reduction of VEGF-A and CTGF expression in diabetic nephropathy is associated with podocyte loss. Kidney Int (2007) 1.63

KIR-ligand mismatches are associated with reduced long-term graft survival in HLA-compatible kidney transplantation. Am J Transplant (2011) 1.62

A pathogenic role for secretory IgA in IgA nephropathy. Kidney Int (2006) 1.58

Quantification of dendritic cell subsets in human renal tissue under normal and pathological conditions. Kidney Int (2007) 1.52

TGF-beta 1 induces proliferation in human renal fibroblasts via induction of basic fibroblast growth factor (FGF-2). Kidney Int (2001) 1.50

Megakaryoblastic differentiation of proerythroblastic K562 cell-line cells. Leuk Res (1984) 1.45

The effect of calcineurin inhibitors and corticosteroids on the differentiation of human dendritic cells. Eur J Immunol (2000) 1.45

The relative radioresistance of interleukin-2 production by human peripheral blood lymphocytes: consequences for the development of a new limiting dilution assay for the enumeration of helper T lymphocyte precursor frequencies. J Immunol Methods (1994) 1.43

Secretion of anti-citrulline-containing peptide antibody by B lymphocytes in rheumatoid arthritis. Arthritis Rheum (2001) 1.42

Rejection of a kidney transplant does not always lead to priming of cytotoxic T cells against mismatched donor HLA class I antigens. Transplantation (2001) 1.41

[Favourable results of the first 2 years of the Dutch paired, living donor, kidney exchange programme]. Ned Tijdschr Geneeskd (2007) 1.39

[Skin cancer and other skin disorders in patients following solid organ transplantation]. Ned Tijdschr Geneeskd (2005) 1.39

CD40 ligation on human cord blood CD34+ hematopoietic progenitors induces their proliferation and differentiation into functional dendritic cells. J Exp Med (1997) 1.38

Interleukin-17 and CD40-ligand synergistically enhance cytokine and chemokine production by renal epithelial cells. J Am Soc Nephrol (2000) 1.32

A soluble form of TRAP (CD40 ligand) is rapidly released after T cell activation. Eur J Immunol (1995) 1.29

Is the proximal tubular cell a proinflammatory cell? Nephrol Dial Transplant (2000) 1.27

Extracellular matrix components and regulators in the airway smooth muscle in asthma. Eur Respir J (2008) 1.26

Differential distribution of CD4(+)CD25(bright) and CD8(+)CD28(-) T-cells in decidua and maternal blood during human pregnancy. Placenta (2006) 1.18

Rapamycin induces apoptosis in monocyte- and CD34-derived dendritic cells but not in monocytes and macrophages. Blood (2001) 1.16

Effects of anti-inflammatory agents on mucosal inflammation induced by infection with gram-negative bacteria. Infect Immun (1990) 1.14

Functional analysis of rheumatoid factor-producing B cells from the synovial fluid of rheumatoid arthritis patients. Arthritis Rheum (1998) 1.14

The formation of competent barrier lipids in reconstructed human epidermis requires the presence of vitamin C. J Invest Dermatol (1997) 1.14

Highly diverged MHC class I mismatches are acceptable for haematopoietic stem cell transplantation. Bone Marrow Transplant (2007) 1.12

How to improve the search for an unrelated haematopoietic stem cell donor. Faster is better than more! Bone Marrow Transplant (2005) 1.11

Dual HLA class I and class II restricted recognition of alloreactive T lymphocytes mediated by a single T cell receptor complex. Proc Natl Acad Sci U S A (2001) 1.11

Allograft-specific cytokine profiles associate with clinical outcome after islet cell transplantation. Am J Transplant (2008) 1.11

The phylogenetically conserved doublet tertiary interaction in domain III of the large subunit rRNA is crucial for ribosomal protein binding. Proc Natl Acad Sci U S A (1993) 1.10

Comparison of doxorubicin and mitoxantrone in the treatment of elderly patients with advanced diffuse non-Hodgkin's lymphoma using CHOP versus CNOP chemotherapy. J Clin Oncol (1995) 1.10

Glucocorticoids transform CD40-triggering of dendritic cells into an alternative activation pathway resulting in antigen-presenting cells that secrete IL-10. Blood (2000) 1.07

Molecular cloning and physical analysis of an 8.2 kb segment of chromosome XI of Saccharomyces cerevisiae reveals five tightly linked genes. Yeast (1992) 1.04

Somatic mutations in human Ig variable genes correlate with a partially functional CD40-ligand in the X-linked hyper-IgM syndrome. J Immunol (1996) 1.03

The superior results of living-donor renal transplantation are not completely caused by selection or short cold ischemia time: a single-center, multivariate analysis. Transplantation (2003) 1.01

Human CD38 ligand. A 120-KDA protein predominantly expressed on endothelial cells. J Immunol (1996) 1.00

An improved immunocytochemical method for the detection of human cytomegalovirus antigens in peripheral blood leucocytes. Histochemistry (1989) 1.00

Accumulation of autoreactive effector T cells and allo-specific regulatory T cells in the pancreas allograft of a type 1 diabetic recipient. Diabetologia (2008) 0.99

An IgM capture enzyme linked immunosorbent assay to detect IgM antibodies to treponemes in patients with syphilis. Genitourin Med (1989) 0.99

Pregnancy can induce long-persisting primed CTLs specific for inherited paternal HLA antigens. Hum Immunol (2001) 0.98

Mannan-binding lectin mediates renal ischemia/reperfusion injury independent of complement activation. Am J Transplant (2012) 0.96

Follicular T helper cells and humoral reactivity in kidney transplant patients. Clin Exp Immunol (2015) 0.96

Differential regulation of metzincins in experimental chronic renal allograft rejection: potential markers and novel therapeutic targets. Kidney Int (2006) 0.96

Expression of HLA class I antigens in transporter associated with antigen processing (TAP)-deficient mutant cell lines. Tissue Antigens (1998) 0.96

Alloreactivity from human viral specific memory T-cells. Transpl Immunol (2010) 0.96

Maturation-resistant dendritic cells induce hyporesponsiveness in alloreactive CD45RA+ and CD45RO+ T-cell populations. Am J Transplant (2006) 0.95

Donor-derived mesenchymal stem cells remain present and functional in the transplanted human heart. Am J Transplant (2008) 0.95

Anti-HLA antibody ligation to HLA class I molecules expressed by endothelial cells stimulates tyrosine phosphorylation, inositol phosphate generation, and proliferation. Hum Immunol (1997) 0.95

Gene expression profiling in the leukemic stem cell-enriched CD34+ fraction identifies target genes that predict prognosis in normal karyotype AML. Leukemia (2011) 0.95

Expression and function of Fas (CD95) on human renal tubular epithelial cells. J Am Soc Nephrol (1997) 0.95

Functional versus structural matching: can the CTLp test be replaced by HLA allele typing? Hum Immunol (2002) 0.95

Selective unresponsiveness to beta cell autoantigens after induction immunosuppression in pancreas transplantation with anti-interleukin-2 receptor antibody versus anti-thymocyte globulin. Clin Exp Immunol (2007) 0.95

TCR cross-reactivity and allorecognition: new insights into the immunogenetics of allorecognition. Immunogenetics (2011) 0.94

Myeloid-associated antigen 3-alpha-fucosyl-N-acetyllactosamine (FAL): location on various granulocyte membrane glycoproteins and masking upon monocytic differentiation. Eur J Immunol (1984) 0.94

Presence of a population of CD20+, CD38- B lymphocytes with defective proliferative responsiveness in the synovial compartment of patients with rheumatoid arthritis. Arthritis Rheum (2001) 0.94

Immunoglobulin-binding sites of human FcalphaRI (CD89) and bovine Fcgamma2R are located in their membrane-distal extracellular domains. J Exp Med (1999) 0.94

Transforming growth factor-beta 1 regulates chemokine and complement production by human proximal tubular epithelial cells. Kidney Int (1998) 0.93

IL-4 and IL-13 augment cytokine- and CD40-induced RANTES production by human renal tubular epithelial cells in vitro. J Am Soc Nephrol (1998) 0.93

Homing of human autoreactive T cells into pancreatic tissue of NOD-scid mice. Diabetologia (2004) 0.92

Renal-cell carcinoma-specific lysis by cytotoxic T-lymphocyte clones isolated from peripheral blood lymphocytes and tumor-infiltrating lymphocytes. Int J Cancer (1996) 0.92

The effect of noninherited maternal antigens in allogeneic transplantation. Semin Hematol (2005) 0.92

Cross-validation of IFN-γ Elispot assay for measuring alloreactive memory/effector T cell responses in renal transplant recipients. Am J Transplant (2013) 0.92

Strategies to work with HLA data in human populations for histocompatibility, clinical transplantation, epidemiology and population genetics: HLA-NET methodological recommendations. Int J Immunogenet (2012) 0.92

Mechanisms of antibody immunotherapy on clonal islet reactive T cells. Hum Immunol (2006) 0.90

On the role of HLA antibodies in hematopoietic stem cell transplantation. Tissue Antigens (2013) 0.90

Functional CD40 antigen on B cells, dendritic cells and fibroblasts. Adv Exp Med Biol (1995) 0.90

Characterization, by immunoprecipitation, of myeloid- and monocyte-specific antigens present on the human promyelocytic cell line (HL-60) in three stages of differentiation. Proc Natl Acad Sci U S A (1981) 0.89

Endogenous-peptide-dependent alloreactivity: new scientific insights and clinical implications. Tissue Antigens (2013) 0.89

HLA class I phenotype and genotype alterations in cervical carcinomas and derivative cell lines. Tissue Antigens (1998) 0.89

Relevance of cytotoxic alloreactivity under different immunosuppressive regimens in clinical islet cell transplantation. Clin Exp Immunol (2009) 0.89

Regulation of synovial B cell survival in rheumatoid arthritis by vascular cell adhesion molecule 1 (CD106) expressed on fibroblast-like synoviocytes. Arthritis Rheum (2000) 0.88

IgA1 glycosylation in IgA nephropathy: as sweet as it can be. Kidney Int (2008) 0.88

Induction of MHC-class I restricted human suppressor T cells by peptide priming in vitro. Hum Immunol (1998) 0.88

The detection of cytotoxic T cells with high-affinity receptors for donor antigens in the transplanted heart as a prognostic factor for graft rejection. Transplantation (1993) 0.87

Elsevier Trophoblast Research Award Lecture: Unique properties of decidual T cells and their role in immune regulation during human pregnancy. Placenta (2010) 0.87

Isolation and molecular characterization of spontaneous mutants of lymphoblastoid cells with extended loss of heterozygosity. Mutat Res (1997) 0.87

Comparison of macrophage phenotype between decidua basalis and decidua parietalis by flow cytometry. Placenta (2008) 0.87

Lipid and ultrastructural characterization of reconstructed skin models. Int J Pharm (2000) 0.87

Epidermal growth factor and temperature regulate keratinocyte differentiation. Arch Dermatol Res (1997) 0.87

Pancreas allograft biopsies with positive c4d staining and anti-donor antibodies related to worse outcome for patients. Am J Transplant (2010) 0.87

Clinical and immunologic aspects of egg donation pregnancies: a systematic review. Hum Reprod Update (2010) 0.86

New tools to monitor the impact of viral infection on the alloreactive T-cell repertoire. Tissue Antigens (2009) 0.86

Immune responses against islet allografts during tapering of immunosuppression--a pilot study in 5 subjects. Clin Exp Immunol (2012) 0.86